Cpx-351 Treatment of Previously Untreated Older aml Patients with High Risk aml Markedly Increases the Response Rate Over 7+3 in Patients with flt3 Mutations

J Lancet, H. Lee Moffitt Cancer Center & Research Institute
G Uy, Washington University
J Cortes, University of Texas MD Anderson Cancer Center
L Newell, Oregon Health & Science University